775th Monthly Meeting – Bernat Olle PhD, January 27, 2020
“Medicines Based on Define Bacterial Consortia“
Bernat Olle, PhD
Chief Executive Officer, Vendanta Biosciences
Dr. Olle is a co-founder and Chief Executive Officer of Vedanta Biosciences. He has been a member of the founding teams of several companies of the PureTech portfolio and served as a member of the Board of Directors of Vedanta Biosciences and Follica Biosciences.
In 2013 Dr. Olle was named “Innovator of the Year” in MIT Technology Review Spain’s “Innovators under 35” awards. He completed his doctoral work at the Chemical Engineering Department at MIT, where he developed a novel method for large-scale bacterial culture. During his graduate work, Dr. Olle was awarded the “la Caixa” fellowship. Dr. Olle received his B.S. in Chemical Engineering from Universitat Rovira i Virgili, in the Republic of Catalonia, his M.S. and PhD. in Chemical Engineering Practice from MIT, and his M.B.A. from the MIT Sloan School of Management. He has published his work in journals including Nature and Nature Biotechnology.
5pm, free reception
Thomas Jefferson University
Bluemle Life Sciences Building
233 S. 10th Street (10th an Locust), Philadelphia 19104
Discounted parking at the garage on 11th and Locust (entrance on 11th Street under the Hamilton Bldg)